Rossari Biotech Limited (NSE:ROSSARI)
India
· Delayed Price · Currency is INR | Market Cap | 25.36B |
| Revenue (ttm) | 22.91B |
| Net Income (ttm) | 1.38B |
| Shares Out | 55.38M |
| EPS (ttm) | 24.85 |
| PE Ratio | 18.43 |
| Forward PE | 16.45 |
| Dividend | 0.50 (0.11%) |
| Ex-Dividend Date | Jun 20, 2025 |
| Volume | 19,094 |
| Average Volume | 38,792 |
| Open | 458.80 |
| Previous Close | 457.95 |
| Day's Range | 455.55 - 466.00 |
| 52-Week Range | 451.45 - 766.00 |
| Beta | 0.13 |
| RSI | 24.67 |
| Earnings Date | Apr 30, 2026 |
About Rossari Biotech
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing li... [Read more]
Financial Performance
In fiscal year 2025, Rossari Biotech's revenue was 20.80 billion, an increase of 13.64% compared to the previous year's 18.31 billion. Earnings were 1.36 billion, an increase of 4.35%.
Financial StatementsNews
Rossari Biotech Ltd (BOM:543213) Q3 2026 Earnings Call Highlights: Navigating Growth Amidst ...
Rossari Biotech Ltd (BOM:543213) Q3 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges
Q3 2026 Rossari Biotech Ltd Earnings Call Transcript
Q3 2026 Rossari Biotech Ltd Earnings Call Transcript
Rossari Biotech Ltd (BOM:543213) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...
Rossari Biotech Ltd (BOM:543213) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Pricing Pressures
Q2 2026 Rossari Biotech Ltd Earnings Call Transcript
Q2 2026 Rossari Biotech Ltd Earnings Call Transcript
Rossari Biotech’s subsidiary wins GST appeal; previous tax order set aside
Rossari Biotech Limited has announced that its subsidiary, Unitop Chemicals Private Limited, has successfully won an appeal against a GST Order issued by the Joint Commissioner, Central GST & Central ...
Rossari Biotech Ltd (BOM:543213) Q3 2025 Earnings Call Highlights: Strong Export Growth and ...
Rossari Biotech Ltd (BOM:543213) Q3 2025 Earnings Call Highlights: Strong Export Growth and Capacity Expansion Drive Performance
Q3 2025 Rossari Biotech Ltd Earnings Call Transcript
Q3 2025 Rossari Biotech Ltd Earnings Call Transcript
Rossari Biotech stock drops 4.28% following Q2 results
Rossari Biotech saw its stock price fall by 4.28%, trading at ₹838.35 as of 9:35 AM today. The drop follows the company’s release of its Q2 FY24-25 earnings, which failed to meet market expectations. ...